FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:775-776 March 8, 2001 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: In response to Tefferi's excellent review of myelofibrosis (April 27 issue),¹ Guardiola and colleagues have provided the results of allogeneic stem-cell transplantation in their patients with myelofibrosis (Aug. 31 issue).² The authors refer to a previous report,³ which included data on 55 patients who underwent transplantation at a number of institutions, including the Fred Hutchinson Cancer Research Center; they then provide information on 11 new patients (with no indication as to where those patients underwent transplantation) and present a brief analysis of the results in all 66 patients. These results show an estimated five-year overall survival rate . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Tefferi, A. (2003). The Forgotten Myeloproliferative Disorder: Myeloid Metaplasia. The Oncologist 8: 225-231 [Abstract] [Full Text]  
• Devine, S. M., Hoffman, R., Verma, A., Shah, R., Bradlow, B. A., Stock, W., Maynard, V., Jessop, E., Peace, D., Huml, M., Thomason, D., Chen, Y.-H., van Besien, K. (2002). Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood 99: 2255-2258 [Abstract] [Full Text]